Concizumab Prophylaxis Reduced Bleeding Rates in Hemophilia

(MedPage Today) -- Compared with on-demand treatment, prophylaxis with concizumab -- designed to achieve hemostasis in all hemophilia types -- reduced annualized bleeding rates among patients who have hemophilia A or B with inhibitors, the...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news